| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 80,981 | 79,739 | 80,955 | | Cost of Revenue | 15,671 | 15,204 | 15,498 | | | Gross Profit | 65,310 | 64,535 | 65,457 | | | Operating Expenses | | Research Development | 15,053 | 17,762 | 18,931 | | Selling General and Administrative | 49,680 | 47,449 | 48,022 | | Non Recurring | 896 | 179 | 1,201 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (319) | (855) | (2,697) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,608 | 3,237 | 1,954 | | Earnings Before Interest And Taxes | 1,289 | 2,382 | (743) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 1,289 | 2,382 | (743) | | Income Tax Expense | 1,195 | 1,061 | 782 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 94 | 1,321 | (1,525) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 94 | 1,321 | (1,525) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $94 | $1,321 | ($1,525) |
|
1.48% Nasdaq 
Income Statement
